Selected abstracts
After careful evaluation, the following abstracts have been selected to present during the conference:
Short talks:
David Andrews, Sunnybrook Research Institute – Direct binding interactions of C-Terminal sequences of BCL-2 family proteins regulate cell death
Guy Brown, University of Cambridge – Cell death by phagocytosis contributes to neurodegeneration
Frank Essmann, Robert Bosch Center for Tumor Diseases – Preferential homotypic interaction of C-Terminal domains from pro-apoptotic effector proteins BAX, BAK and BOK
Kamyar Hadian, Helmholtz Munich – Suppression of ferroptosis by vitamin A or radical-trapping antioxidants is essential for neuronal development
Esther Hoste, Ghent University – Stabilization of beta-catenin averts dermatitis caused by OTULIN deficiency
Walker Jackson, Linköping University – Microglia do something strange to their ribosomes during neuroinflammation
Ana Janic, Universidad Pompeu Fabra – Combined absence of TRP53 target genes ZMAT3, PUMA and p21 cause a high incidence in mice
Hiroyasu Nakano, Toho University School of Medicine – Live cell imaging of necroptosis and the release of DAMPs in vitro and in vivo
Flash talks:
Georgia Atkin-Smith, Walter and Eliza Hall Institute – Identification of endothelial cell extracellular vesicles as a biomarker of vascular degradation during blood malignancies
Ilaria Deidda, University Medical Center Göttingen, Georg-August University – RUNX1 Modulates Apoptosis via Epigenetic Reprogramming in Pancreatic Cancer
Roberto Fernández Acosta, University of Antwerpen – Epigenetic reconditioning of ferroptosis-resistant high-risk neuroblastoma: Ctrl+Alt+Del for tumor defense machinery
Melanie Grusdat-Pozdeev, University of Luxembourg – Glutathione regulates natural killer cell immunity and mediates tumor control
Kirsten Kenney, University of Queensland – Corticosterone Dysregulates NLRP3 Inflammasome Signalling
Svenja Lorenz, Helmholtz Center Munich – Neuronal ferroptosis in mice causes signatures reminiscent of neurodegenerative diseases in man
Francesca Rizzollo, VIB – KU Leuven – Iron Trafficking and ferroptosis vulnerability in melanoma is controlled by mitochondria-lysosome contact tethering
Anna Saorin, University of Zurich, Kinderspital Zurich – Transcriptional remodeling shapes therapeutic vulnerability to necroptosis in acute lymphoblastic leukemia
Ege Solel, University of Bergen – Impact of GSDME on Pyroptosis in Glioblastoma
Wulf Tonnus, Dresden University Hospital – Additive STING activation shifts cisplatin toxicity from kidney injury to liver failure by GSDMD-dependent NETosis
Iratxe Uranga Murillo, Health Research Institute of Aragon – FasL, a crucial host factor driving COVID-19 pathology and lethality
Important deadlines
Abstract submission period: 1 March – 16 June 2024 – Second deadline: 7 July.
New deadline extended until 31 August! For posters only!!
Abstract submitted after 7 July will be accepted for posters and will not be considered for oral presentation.
Announcement selected abstracts for oral presentation : End of July- mid August
Procedure
-
Abstract must be submitted through the registration platform
-
Please upload in format .docx
-
File should not exceed 5MB
-
Please use the template provided
-
During submission, you can chose if applying for poster and/or oral presentation (not anymore, as of 8 July abstract can be submitted only for posters)
-
If you apply for oral presentation you may be selected for a short (12+3 min.) or flash (5+2 min.) talk. For flash talks, priority is given to young scientists
-
Scientists selected for a flash talk will benefit from a travel grant up to 1.000 €
-
The 3 best posters will receive a prize during the prize ceremony at the end of the conference